You are invited to participate in the Acceleron A011-12-FR study. This app is specifically intended for study participants France in the Acceleron A011-12-FR study only. This Phase 3 study is being conducted to assess the long-term safety, tolerability, and efficacy of sotatercept in PAH. Long-term followup of patients receiving sotatercept is important to understand themaintenance and durability of treatment effect (especially in thepresence of background PAH therapy) and to provide greateropportunity for pharmacovigilance following sotatercept treatment inthe selected patient populations.
Soteria eDiary (FR)
